http://www.freshnews.com/news/biotech-biomedical/ California Tech News Updated Daily! BioTech / BioMedical / Medical en-us Tue, 08 Jul 2008 18:20:05 -0700 1000 http://www.freshnews.com/news/biotech-biomedical/article_44320.html 2008-07-08 International Stem Cell Corporation (OTCBB: ISCO) announced today a new collaboration with leading stem cell researcher Jose Cibelli at Michigan State University as part of ISCO’s ongoing strategy to work with scientific leaders across the world to expand the scientific data relating to parthenogenetic stem cells. Professor Cibelli will study gene... http://www.freshnews.com/news/biotech-biomedical/article_44315.html 2008-07-08 Invitrogen Corporation, (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light HER2 CISH Kit, indicated as an aid in the assessment of breast cancer patients for whom trastuzumab (Herceptin... http://www.freshnews.com/news/biotech-biomedical/article_44313.html 2008-07-07 Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) announced today that it is resuming clinical investigation of the Toll-Like Receptor-7 (TLR7) mechanism for the treatment of chronic hepatitis C. Based on preclinical pharmacology testing and the results of completed 13-week GLP animal toxicology studies, Anadys has received clearance to initiate a clinical trial of... http://www.freshnews.com/news/biotech-biomedical/article_44307.html 2008-07-07 The Society of Plastics Engineers in their Annual Thermoforming Division Meeting selected the INFINITI Analyzer from AutoGenomics as a recipient of the artistic Multi-Part design award. The award given was based on revolutionary visual appeal, functionality and futuristic design. "We are honored to receive this award from the Society of... http://www.freshnews.com/news/biotech-biomedical/article_44283.html 2008-07-02 PainReform and Encore Therapeutics today announced that the two companies have entered into a licensing and development agreement related to Encore Therapeutics’ ETI-211 product for the treatment of post surgical pain. The product, which is administered subdermally using Encore Therapeutics proprietary Phospholipid Gel technology, is currently in pre clinical... http://www.freshnews.com/news/biotech-biomedical/article_44282.html 2008-07-02 Sequenom, Inc. (NASDAQ: SQNM), a leading provider of genetic analysis solutions, today announced the launch of the iSEQ application software, a MassARRAY comparative sequence analysis application for automated, high-throughput identification and typing of microbes and viruses, as well as human disease-related molecular markers. This product is directed toward the... http://www.freshnews.com/news/biotech-biomedical/article_44281.html 2008-07-02 Sequenom, Inc. (NASDAQ:SQNM) today announced that the underwriters of its previously announced common stock offering that priced on June 25, 2008 have exercised in full an option to purchase an additional 825,000 shares of its common stock. Including the additional shares being purchased, the offering will total 6,325,000 shares... http://www.freshnews.com/news/biotech-biomedical/article_44280.html 2008-07-02 PURE Bioscience (NASDAQ: PURE) today announced the strengthening of its program to develop silver dihydrogen citrate (SDC)-based pharmaceutical products with the addition of a new development partner, FTA Therapeutics, LLC (FTA). PURE has entered into an agreement with FTA for the development and licensing of additional silver dihydrogen citrate (SDC)-based products... http://www.freshnews.com/news/biotech-biomedical/article_44279.html 2008-07-02 MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data. To date, MicroIslet has seen no adverse events attributable to MicroIslet-P in its animal models. The Company has tested hundreds of rodents... http://www.freshnews.com/news/biotech-biomedical/article_44275.html 2008-07-01 Metabasis Therapeutics (Nasdaq: MBRX), announced today that Dr. Paul Laikind, president and chief executive officer, will present at the Collins Stewart 4th Annual Growth Conference at the Mandarin Oriental Hotel in New York, NY. Dr. Laikind is scheduled to present on Wednesday, July 9, at 3:00 p.m. Eastern Time... http://www.freshnews.com/news/biotech-biomedical/article_44272.html 2008-07-01 ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) today announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU (5 fluorouracil), for the treatment of first-line metastatic colorectal cancer. The primary endpoint of the study was progression-free survival, which is expected... http://www.freshnews.com/news/biotech-biomedical/article_44259.html 2008-07-01 Illumina, Inc. (NASDAQ:ILMN) today announced that researchers participating in a new initiative funded by the Wellcome Trust selected Illumina’s Infinium HD BeadChips to analyze 90,000 DNA samples. This new initiative aims to decipher the molecular basis of human disease and includes participation from leading research groups around the globe.... http://www.freshnews.com/news/biotech-biomedical/article_44258.html 2008-07-01 Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India. Aethlon previously disclosed plans to initiate the “first-in-man” clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which causes Acquired Immune Deficiency...